DUBLIN, Aug. 20, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

A new report titled, "Global biosimilars/follow-on-biologics market (types, applications and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020", suggests that the global biosimilars market would reach $35 billion by 2020 from the estimated $1.3 billion in 2013. Deeper penetration with clearer regulatory pathways in developed markets and higher efficacy & safety in emerging markets will back the market growth during the forecast period.

Over 10 blockbuster biologics with annual sales of $60 billion are facing patent expiries in Europe and in the U.S. during the next four years. Top pharmaceutical manufacturing brands are repositioning their strategic agendas from approvals to product launches to gain market capitalization. "Biosimilars developers have been using emerging markets with less intellectual property protection as their launch pad for established markets" say AMR analysts.

Key Topics Covered:

CHAPTER 1 INTRODUCTION

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 MARKET OVERVIEW

CHAPTER 4 GLOBAL BIOSIMILARS/FOLLO-ON-BIOLOGICS MARKET BY TECHNOLOGY

CHAPTER 5 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET BY PRODUCT TYPE

CHAPTER 6 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET BY APPLICATIONS

CHAPTER 7 GLOBAL BIOSIMILARS / FOLLOW-ON-BIOLOGICS MARKET BY SERVICES

CHAPTER 8 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET BY GEOGRAPHIES

CHAPTER 9 KEY PRODUCTS AND RECENT ACTIVITIES BY GEOGRAPHY

CHAPTER 10 COMPANY PROFILES

Companies Mentioned:

  • Biocon
  • Biogen idec Inc
  • Celltrion
  • Genentech (Roche Group)
  • Hospira
  • LG Life Sciences
  • Merck Serono (Merck Group)
  • Novartis (Sandoz)
  • Synthon Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.

For more information visit http://www.researchandmarkets.com/research/qftx4c/global

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Copyright 2014 PR Newswire